Expression of concern

Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape

Paper Information

Record ID:
20801
Author(s):
Meenakshi Hegde
Malini Mukherjee
Zakaria Grada
Antonella Pignata
Daniel Landi
Shoba A Navai
Amanda Wakefield
Kristen Fousek
Kevin Bielamowicz
Kevin K H Chow
Vita S Brawley
Tiara T Byrd
Simone Krebs
Stephen Gottschalk
Winfried S Wels
Matthew L Baker
Gianpietro Dotti
Maksim Mamonkin
Malcolm K Brenner
Jordan S Orange
Nabil Ahmed
Journal:
The Journal of Clinical Investigation (JCI) ( American Society for Clinical Investigation )
Publication Date:
July 18, 2016
Retraction Date:
July 02, 2019 (6.4 years years ago)
Subjects:
Broad Categories:
Medicine Biology Biochemistry
Institutions:
Country:
🇺🇸 United States
Article Type:
Research Article
Publisher:
American Society for Clinical Investigation
Open Access:
Yes
DOI:
10.1172/JCI83416
PubMed ID:
27427982
Retraction PubMed ID:
31264975

Expression of concern Details

Retraction Reasons:
Nature of Retraction:

Expression of concern

Retraction Notice:
10.1172/JCI131246

Citations (542)

542
Total Citations
385
Post-Retraction
(71.0%)
117
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
6 Within 30 days
67 Within 1 year
239 After 2+ years
2130 Days since retraction (latest)
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jan 2024
1663 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jan 2024
1661 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jan 2024
1651 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jan 2024
1651 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jan 2024
1646 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Nov 2023
1589 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Oct 2023
1581 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Sep 2023
1541 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Sep 2023
1536 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Sep 2023
1536 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Sep 2023
1533 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Sep 2023
1522 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Aug 2023
1518 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Aug 2023
1516 days after retraction
Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Greta Maria Paola Giordano Attianese, Sarah Ash, Melita Irving
Immunological Reviews Open Access
Published: Aug 2023
18 citations
1497 days after retraction
Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer
Ye Li, Katayoun Rezvani, Hind Rafei
Immunological Reviews Open Access
Published: Aug 2023
22 citations
1497 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Aug 2023
1491 days after retraction
Heterogeneity of the tumor immune microenvironment and clinical interventions
Jin Zheng, Qin Zhou, Jianan Cheng et al. (5 authors)
Frontiers of Medicine
Published: Aug 2023
4 citations
1491 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jul 2023
1484 days after retraction
Chimeric antigen receptor-natural killer cells: a promising sword against insidious tumor cells
Tahereh Hojjatipour, Zahra Sharifzadeh, Amirhosein Maali et al. (4 authors)
Human Cell
Published: Jul 2023
3 citations
1480 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jul 2023
1463 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jul 2023
1462 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jul 2023
1461 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jul 2023
1460 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jul 2023
1460 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1458 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1458 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1455 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1452 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1448 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1444 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1437 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1436 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Jun 2023
1430 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: May 2023
1425 days after retraction
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
Jessica Foster, Marta M. Alonso, Elias Sayour et al. (10 authors)
Neoplasia Open Access
Published: May 2023
7 citations
1423 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: May 2023
1423 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: May 2023
1422 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: May 2023
1399 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: May 2023
1399 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Apr 2023
1396 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Apr 2023
1369 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Mar 2023
1358 days after retraction
Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development
Ninglin Zhao, Yingjie Song, Xiangqian Xie et al. (8 authors)
Signal Transduction and Targeted Therapy Open Access
Published: Mar 2023
45 citations
1348 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Mar 2023
1347 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Feb 2023
1337 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Feb 2023
1336 days after retraction
CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature
Published: Feb 2023
387 citations
1331 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Feb 2023
1330 days after retraction
Paper citing Tandem CAR T cells targeting HER2 and IL13Ra2 miti...
Unknown Authors
Unknown Journal
Published: Feb 2023
1325 days after retraction
Quick Stats
Total Citations: 542
Years Since Retraction: 6.4 years
Open Access: Yes
Last Checked: Never
Related Papers
Sorting protein VPS33B regulates exosomal autocrine signali…
The Journal of Clinical Investigation (JCI) • 74 citations
EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulate…
The Journal of Clinical Investigation (JCI) • 82 citations
Hydrogen sulfide attenuated tumor necrosis factor-α-induced…
PLoS One • 121 citations
Berberine and cinnamaldehyde together prevent lung carcinog…
Oncotarget • 41 citations
NK cell heparanase controls tumor invasion and immune surve…
The Journal of Clinical Investigation (JCI) • 94 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice